^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
ladiratuzumab vedotin (SGN-LIV1A)
i
Other names: SGN-LIV1A, Anti-LIV-1 ADC, MK-6440
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Merck (MSD), Pfizer
Drug class:
Microtubule inhibitor, LIV-1-targeted antibody-drug conjugate
Related drugs:
